SciNote Pricing Overview

SciNote does not offer a permanent free plan, but it does provide a free trial that lets users to test the product before committing to a paid plan. Trial availability and duration may vary, so users should review the seller's official pricing page for the most current details.

SciNote's pricing is best suited for small biotech and pharmaceutical teams, based on G2 review demographics, where the majority of reviewers come from small businesses with 50 or fewer employees in biotechnology, research, and pharmaceuticals. G2 reviewers in these segments consistently praise SciNote's affordability and ease of implementation for lean teams. Academic labs and early-stage cell therapy or biopharma companies also appear frequently among satisfied reviewers. Mid-market CROs and GxP-regulated contract labs may find SciNote's pricing less optimal, as G2 reviewers from those segments flag missing advanced features like native instrument integration and external client portals that would justify higher spend.

SciNote offers a free version alongside paid plans, according to G2 reviewers. G2 users confirm the free version covers core ELN functionality including protocols, experiments, and basic inventory, with at least one academic lab reporting their entire department adopted SciNote starting from the free tier. SciNote's paid plans unlock add-ons such as advanced stock management, the relationships module, 21 CFR Part 11-compliant e-signatures, and enterprise integrations. G2 reviewers flag that features like co-signing workflows and certain inventory automation require paid upgrades. One reviewer specifically noted frustration that signature functionality for peers required upgrading accounts, indicating access controls and compliance features are gated behind SciNote's paid tiers.

G2 reviewers of SciNote are broadly positive on value, with the platform averaging 4.0/5 across a large review set. Multiple G2 users in biotechnology and pharmaceuticals explicitly call SciNote affordable and competitively priced for its feature set. One reviewer notes it offers great value for cost, another calls it affordable, and a third highlights competitive pricing relative to included features. The main value concern raised by G2 reviewers is per-user cost scaling, with one noting it becomes expensive for multi-user teams, and another flagging that add-ons are bundled into large packages rather than sold individually. One hospital reviewer acknowledged high cost but noted discount options were available.